-
公开(公告)号:US20200263171A1
公开(公告)日:2020-08-20
申请号:US16644559
申请日:2018-09-07
申请人: PSOMAGEN, INC.
发明人: Zachary Apte , Jessica Richman , Daniel Almonacid , Eduardo Morales , Rodrigo Ortiz , Nicolas Ordenes , Juan Jimenez , Cristian Bravo , Natalia Scioscia , Eduardo Olivares , Luis Leon , Paulo Covarrubias , Felipe Sepulveda , Felipe Melis
IPC分类号: C12N15/10 , C12Q1/6874
摘要: Embodiments of a method and/or system, such as for preparation of a normalized library for sequencing such as next-generation sequencing, can include one or more of: generating one or more normalized amplicon libraries; generating one or more normalized microbial community-associated libraries; and/or generating one or more normalized combined sequence libraries associated with amplicon-associated sequencing and microbial community-associated sequencing.
-
公开(公告)号:US11001900B2
公开(公告)日:2021-05-11
申请号:US16115542
申请日:2018-08-28
申请人: PSOMAGEN, INC.
发明人: Zachary Apte , Elisabeth Bik , Sara W. Bird , Luis E. Leon , Pamela A. Nieto , Victor Alegria-Mera , Cristian Bravo , Juan P. Cardenas , Paulo Covarrubias , Sarah L. Gupta , Kira Harman , Juan Jimenez , Felipe Melis-Arcos , Camila F. Navas , Harold Nunez , Eduardo Olivares , Nicolas Ordenes-Aenishanslins , Francisco J. Ossandon , Ignacio Varas , Patricia Vera-Wolf , Donna Marie B. Hongo , Laurens Kraal , Nathaniel A. Walton , Amanda Morton , Juan P. Bustamante , Kwasi Addae , Graham Gass , Katia Soto-Liebe , Juan A. Ugalde , Eduardo H. Morales , Daniel Almonacid , Jessica Richman
IPC分类号: C12Q1/689 , C12Q1/04 , C12Q1/70 , G16B5/00 , G16B20/00 , G16B30/00 , G16B40/00 , C12Q1/6883 , G16H10/40 , G16H50/30 , G16H50/20 , G16B40/20 , G16B40/30 , G16B50/30
摘要: Embodiments of a method and/or system for characterizing one or more female reproductive system-related conditions can include determining a microorganism dataset associated with a set of subjects; and/or performing a characterization process associated with the one or more female reproductive system-related conditions, based on the microorganism dataset, where performing the characterization process can additionally or alternatively include performing a female reproductive system-related characterization process for the one or more female reproductive system-related conditions, and/or determining one or more therapies.
-